GENE ONLINE|News &
Opinion
Blog

Breast Cancer
Everest and Gilead Announce Positive Phase 3 Results of Breast Cancer Drug
2022-06-06
EU Expands Merck’s Keytruda Use on Breast Cancer
2022-05-25
REVEAL GENOMICS and Dana-Farber Cancer Institute Team Up to Research Breast Cancer
2022-04-29
FDA Grants AstraZeneca and Daiichi Sankyo’s Breast Cancer Drug Its Fifth Breakthrough Label
2022-04-28
Alymsys Becomes the Third Biosimilar for Bevacizumab Approved by FDA
2022-04-20
Recent Advances in Breast Cancer Treatments: An Overview
2022-01-15
Eli Lilly’s Early Breast Cancer Drug Gets FDA Nod but Faces Tricky Rollout
2021-10-14
Checkpoint Inhibitors as Part of Neoadjuvant Therapy in TNBC: Should We Use Them or Not?
2021-10-03
Pfizer Inks Second Collaboration with Arvinas, Makes Billion-Dollar Investment on a Novel Agent for Breast Cancer Therapy
2021-07-26
Day 2 ASCO 2021 Roundup: Focus on Equity in Cancer Care, Highlights from Breast Cancer and Gastrointestinal Cancer Studies
2021-06-06
R&D
Recent Advances in Triple Negative Breast Cancer Treatments
2021-04-26
R&D
New Strategies to Improve Adoptive Cell Therapies for Solid Tumors
2021-04-14
Gilead’s Breast Cancer Drug that Came off a $21 Billion Buyout Finally Gets FDA’s Full Approval
2021-04-09
FDA Rejects Athenex’s Breast Cancer Treatment, Recommends Another Clinical Trial
2021-03-03
Roche Bags EU Nod for a Novel Delivery Method in Breast Cancer Treatment
2020-12-25
1 2 3 4
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top